These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8966918)

  • 41. [Tumor necrosis factor-alpha kinetics during renal replacement therapy in patients with sepsis and multiple organ failure].
    Timokhov VS; Iakovleva II; Kalashnikova EA; Semenov VN
    Ter Arkh; 1997; 69(11):38-9. PubMed ID: 9483744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of the molecular adsorbent recycling system in the treatment of postoperative hepatic failure and septic multiple organ dysfunction--preliminary results.
    Rittler P; Ketscher C; Inthorn D; Jauch KW; Hartl WH
    Liver Int; 2004 Apr; 24(2):136-41. PubMed ID: 15078478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of extracorporeal efferent detoxication (EED) methods inclusion in the severe community-acquired pneumonia (CAP) treatment.
    Makarevich A; Pancratova J; Kyrkovsky V
    Adv Med Sci; 2006; 51():73-87. PubMed ID: 17357282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The correlation between preoperative pulmonary function and postoperative pulmonary complications in the surgical treatment of scoliosis].
    Zhang JG; Wang W; Qiu GX; Liu Y; Qian WW; Weng XS; Yang XY; Wang YP; Ren YZ; Tong ZH; Cao Y
    Zhonghua Wai Ke Za Zhi; 2004 Nov; 42(21):1296-8. PubMed ID: 15634428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
    Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The use of extracorporeal detoxication methods in treating infectious disease patients].
    Ivanov KS; Gurevich KIa; Shvedov AK
    Voen Med Zh; 1992; (4-5):74-7. PubMed ID: 1523824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Characteristics of the correction of the blood aggregate condition during extracorporeal hemosorption in hematologic patients].
    Katsadze IuL; Ganapiev AA
    Ter Arkh; 1985; 57(10):80-5. PubMed ID: 4082003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Biological monitoring and prevention of complications from antithrombotic agents].
    Samama MM; Kher A
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1569-77. PubMed ID: 9092420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Selective detoxication of the portal vein blood in toxic hepatopathy in patients with peritonitis].
    Vatazin AV; Kruglov EE; Fomin AM; Suslov VP; Koshelev RV; Astakhov PV
    Anesteziol Reanimatol; 2002; (2):73-6. PubMed ID: 12227007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A rare cause of pulmonary-renal syndrome with autoantibodies: primary antiphospholipid syndrome].
    Berezne A; Karras A; Martinez F; Droz D; Clauvel JP; Legendre C
    Nephrologie; 2004; 25(2):53-7. PubMed ID: 15119221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Introduction to Extracorporeal Multiple Organ Support.
    Vincent JL
    Blood Purif; 2019; 48(2):97-98. PubMed ID: 30304716
    [No Abstract]   [Full Text] [Related]  

  • 52. [Sorption detoxification in the treatment of patients with tuberculosis].
    Pidufala GR
    Vrach Delo; 1991 Jun; (6):25-8. PubMed ID: 1891842
    [No Abstract]   [Full Text] [Related]  

  • 53. [Experience in the treatment of severe forms of sepsis by extracorporeal therapy and hyperbaric oxygenation].
    Zhidkov KP; Klechikov VZ; Bogatyr' MN
    Anesteziol Reanimatol; 1997; (3):49-51. PubMed ID: 9289988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Complications of sorption-application therapy of purulent wounds].
    Pavlov VV; Pleshakov VP; Maĭborodin IV
    Khirurgiia (Mosk); 1999; (1):12-3. PubMed ID: 10050502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical characteristics of patients emergently hospitalized with pulmonary hemorrhage].
    Kirgintsev AG; Ivanov AV
    Probl Tuberk; 2000; (4):28-32. PubMed ID: 10981429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Catastrophic antiphospholipid syndrome: report of 4 cases.
    Sinico RA; Di Toma L; Sabadini E; Renoldi P; Li Vecchi M
    J Nephrol; 2007; 20(6):739-44. PubMed ID: 18046677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRISM-PLUS study.
    Huynh T; Piazza N; DiBattiste PM; Snapinn SM; Wan Y; Pharand C; Theroux P
    Int J Cardiol; 2005 Apr; 100(1):73-8. PubMed ID: 15820288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Efferent therapy in the combined treatment of diffuse suppurative peritonitis].
    Neĭmark MI; Elizar'ev AIu; Raĭkin ID
    Anesteziol Reanimatol; 1996; (3):73-4. PubMed ID: 8967631
    [No Abstract]   [Full Text] [Related]  

  • 59. Impact of preoperative treatment strategies on the early perioperative outcome in neonates with hypoplastic left heart syndrome.
    Stieh J; Fischer G; Scheewe J; Uebing A; Dütschke P; Jung O; Grabitz R; Trampisch HJ; Kramer HH
    J Thorac Cardiovasc Surg; 2006 May; 131(5):1122-1129.e2. PubMed ID: 16678599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Multiorgan failure in pulmonary embolism].
    Novohradský V; Kozák M; Carda M
    Rozhl Chir; 2002 Jun; 81(6):290-2. PubMed ID: 12149871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.